ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1402	National Cancer Institute	Html	en	Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood non-Hodgkin lymphoma.	T-cell lymphoblastic lymphoma 0.616756 mediastinal B-cell lymphoma 0.654258 Pediatric Non-Hodgkin Lymphoma 0.567507 mature B-cell 0.675642 Engl J Med 0.525188 B-cell non-Hodgkin lymphoma 0.746462 children 0.65412 mature B-cell leukemia 0.544897 cell lymphoma outcome 0.543686 lymphoblastic lymphoma stage 0.540387 pediatric-type follicular lymphoma 0.574777 large B-cell lymphomas 0.528398 large cell lymphoma 0.779097 pediatric anaplastic lymphoma 0.540067 adolescents 0.539146 Burkitt lymphoma 0.638477 mediastinal large B-cell 0.573557 childhood B-cell non-Hodgkin 0.52722 diffuse large b-cell 0.665879 anaplastic large-cell lymphoma 0.616485 center-derived B-cell lymphoma 0.609426 Burkitt lymphoma incidence 0.577758 cell lymphoma cases 0.534062 Leuk Lymphoma 0.529329 large B-cell lymphoma 0.815777	cell lymphoma patients 0.528087 mature B-cell lymphoma 0.609056 et al. 0.801373 Br J Haematol 0.629196 Cairo MS 0.571856 primary mediastinal B-cell 0.5557 Pediatr Blood Cancer 0.817055 childhood B-cell 0.532059 diffuse large-B-cell lymphoma 0.523303 Secondary non-Hodgkin lymphoma 0.572995 mature B-cell non-Hodgkin 0.643468 lymphoblastic lymphoma 0.618923 Abstract 0.750082 cancer group 0.553869 lymphoma 0.902345 Clin Oncol 0.644225 childhood non-Hodgkin lymphoma 0.549011 high-stage Burkitt lymphoma 0.543865 B-cell lymphoma subgroups 0.565819 non-hodgkin lymphoma 0.766463 recurrent non-Hodgkin lymphoma 0.543912 anaplastic large cell 0.660109 oncology group 0.53775 Burkitt-like lymphoma 0.528197	CLICK HERE
1451	National Cancer Institute	Html	null	Unusual Cancers of Childhood Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of unusual cancers of childhood such as cancers of the head and neck, chest, abdomen, reproductive system, skin, and others.			CLICK HERE
1498	National Cancer Institute	Html	en	Lip and Oral Cavity Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of lip and oral cavity cancer.	retromolar trigone 0.457467 lesions 0.51335 cone radiation therapy 0.449302 stage IV tumors 0.388096 station nodes 0.404586 radiation therapy. 0.414397 lip 0.39553 larger lesions 0.408688 oral cavity cancer 0.391261 upper gingiva 0.475854 local recurrence 0.42994 early lesions 0.429301 World Health Organization 0.457603 patients 0.399778 early cancers 0.501066 small cancers 0.408462 interstitial radiation sources 0.430653 advanced cancers 0.459827 neck cancers 0.384982 lymph nodes 0.55579 radiation therapy 0.932988 cancers 0.524279 lymph node drainage 0.410464 anterior tongue 0.427579 treatment 0.469588	radiation modifiers 0.407878 lichen planus 0.388656 radiation oncologists 0.396567 posterior cervical nodes 0.416429 oral cavity tumors 0.396446 cervical lymph nodes 0.491468 distant metastases 0.456495 regional lymph node 0.41022 Precancerous lesions 0.394835 buccal mucosa 0.38527 radical radiation therapy 0.447851 moderately advanced lesions 0.488166 external-beam radiation therapy 0.451492 oral cavity cancers 0.431571 cosmetic results 0.421228 radiation treatment 0.406818 stage 0.394996 hard palate 0.551429 local control rates 0.433778 oral cavity 0.569458 regional lymph nodes 0.478345 radiation oncologist 0.475855 Small superficial cancers 0.415309 squamous cell carcinoma 0.47595	CLICK HERE
1671	National Cancer Institute	Html	en	Oral Cavity and Oropharyngeal Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing cancer of the lip or mouth and about approaches that may help in the prevention of this disease.	cancer risk factors 0.223252 Cancer prevention 0.365011 cancer prevention trials 0.261397 cancer protective factor 0.204761 prevention clinical trials 0.211212 oropharyngeal cancers 0.216475 oral HPV infection 0.208202 protective factors 0.215254 oral HPV 0.208586 following PDQ summaries 0.206276 oropharyngeal cancer prevention 0.350667 PDQ cancer information 0.33357 cavity cancer forms 0.258314 oral cavity cancer 0.981873 Oropharyngeal cancer forms 0.281694	alcoholic drinks 0.202431 Prevention Editorial Board 0.202298 National Cancer Institute 0.263899 clinical trials 0.351443 oral cancer 0.226352 cancer information summary 0.25617 PDQ Oral Cavity 0.273609 oropharyngeal cancer increases 0.352455 cancer risk factor 0.224482 NCI PDQ cancer 0.229249 cavity cancer prevention 0.250253 cancer clinical trials 0.204322 risk factors 0.306174 cancer information summaries 0.200668 comprehensive cancer information 0.201344	CLICK HERE
1830	National Cancer Institute	Html	es	Tratamiento de la leucemia mielógena crónica (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mielógena crónica.	imatinib treatment 0.309815 associated with 0.307718 Saglio G 0.311488 Imatinib plus 0.308886 mayoría imatinib 0.309903 with chronic myeloid 0.371977 Sin embargo 0.315782 Kantarjian HM 0.372759 standard-dose imatinib therapy 0.309084 myeloid leukemia patients 0.32923 Cortes JE 0.313764 chronic myeloid leukemia 0.996248 or imatinib 0.327327 myelogenous leukemia patients 0.309285 Philadelphia chromosome-positive 0.307544 TCM alogénico 0.343658 chronic myelomonocytic leukemia 0.306491 patients with chronic 0.376511 Rosti G 0.305694 leucemia mielógena 0.3214 stem cell transplantation 0.309631 chronic myelogenous leukemia 0.537094 with imatinib 0.31893 Guilhot F 0.305867 vs imatinib 0.308365	Chronic Leukemia 0.308312 Versus Imatinib Study 0.318542 patients with philadelphia 0.308802 dasatinib or imatinib 0.311418 versus imatinib 0.331295 Jabbour E 0.308732 patients with 0.421072 myeloid leukemia treated 0.313347 Treatment-Naïve Chronic Myeloid 0.309823 marrow transplantation 0.313614 leukemia treated with 0.314928 Dasatinib Versus Imatinib 0.321251 bone marrow transplantation 0.310388 Leukemia Patients Trial 0.308496 newly diagnosed chronic 0.341689 treated with imatinib 0.310526 imatinib depends 0.308315 imatinib versus 0.310194 chronic granulocytic leukemia 0.306345 tirosina cinasa 0.443764 Clin Oncol 0.407181 bone marrow 0.312247 myelogenous leukemia with 0.307043 treated with 0.317153	CLICK HERE
1832	National Cancer Institute	Html	es	Tratamiento del cáncer de vagina (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vagina.	Obstet Gynecol 0.283662 Lippincott Williams 0.242575 vagina funcional 0.243946 berek js 0.239666 Carlone M 0.228988 prognostic factors 0.719083 vaginal cancer 0.473271 Sin embargo 0.237061 American Cancer Society 0.229383 Frank SJ 0.247276 Definitive radiotherapy 0.277726 institutional experience 0.233025 Radiat Oncol Biol 0.893767 DeVita VT Jr 0.277942 Camel HM 0.230789 Jhingran A 0.245715 Gynecol Oncol 0.996446 Rosenberg SA 0.240229 primary invasive squamous 0.2365 squamous carcinoma 0.334954 Lee P 0.243278 Galakatos AE 0.229807 vagina treated with 0.406995 primary carcinoma 0.405837 Markman MA 0.223742	estadio ii 0.224737 Seski J 0.269409 vaginal intraepithelial neoplasia 0.27229 Perez CA 0.260508 Wheeler JA 0.267137 Cancer Staging Manual 0.259578 Levenback C 0.24589 Definitive irradiation 0.237883 Chen AS 0.271634 Eifel PJ 0.224915 PDQ Tratamiento 0.250686 New York 0.251038 long-term evaluation 0.231124 9th ed 0.223747 Zagars GK 0.268986 Oncol Biol Phys 0.938039 invasive squamous carcinoma 0.314957 Dundas G 0.228633 Treat Options Oncol 0.229038 cuello uterino 0.451234 Gynecol Cancer 0.242612 Twenty-year review 0.228463 AJCC Cancer Staging 0.261483 squamous cell carcinoma 0.643647	CLICK HERE
1917	National Cancer Institute	Html	es	Tratamiento del cáncer de vesícula biliar (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vesícula biliar.	terapia paliativa mejora 0.52497 pequeñas incisiones 0.470446 siguientes procedimientos 0.45044 estadio iv 0.621294 siguientes aspectos 0.501569 estadio ii 0.777223 flexible llamada endoprótesis 0.532683 siguientes razones 0.497295 siguientes tipos 0.464265 vía oral 0.447019 rayos x 0.470622 ondas sonoras 0.475252 estadio iva 0.502715 National Cancer Institute 0.448229 siguientes riesgos 0.438065 Instituto Nacional 0.69474	estadio iiia 0.507081 PDQ Tratamiento 0.493466 siguientes problemas 0.500188 presente sección 0.442764 partes distantes 0.453382 Physician Data Query 0.580893 estadio i 0.784786 siguientes sitios 0.573736 biliar libera bilis 0.930425 antígeno carcinoembrionario 0.484555 colangiopancreatografía retrógrada 0.478582 ecografía abdominal 0.479387 intestino delgado.ampliar anatomía 0.581644 siguientes enlaces 0.446364 laparoscopia ayuda 0.464844	CLICK HERE
1932	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) masculino (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama) masculino.	proteína tipo factor 0.688463 siguientes procedimientos 0.676775 ensayo clínico quizás 0.629367 masculino causa efectos 0.681409 estadio iv 0.660278 siguientes aspectos 0.673259 causa hinchazón 0.616649 pared torácica).ampliar mastectomía 0.62845 siguientes tipos 0.637367 estadios ia 0.617736 ganglio linfático centinela 0.976846 metastásico recién 0.62148 rayos x 0.618438 estadio ib 0.633026 enlace drugs approved 0.678672 estadio ia 0.632429 parientes mujeres 0.619901 Características genéticas 0.619237 National Cancer Institute 0.617425 siguientes riesgos 0.617906 nota cambios 0.619802 Instituto Nacional 0.630039	cuáles lesiones 0.617135 PDQ Tratamiento 0.673691 antecedentes familiares 0.667022 estadio iiic 0.707564 estadio iiib 0.663127 Drugs Approved 0.68451 partes distantes 0.61448 Physician Data Query 0.660883 siguientes sitios 0.627559 Breast Cancer 0.680102 siguientes características 0.628479 siguientes terapias 0.621354 quede.ampliar cirugía 0.621258 cuerpo llamada ecograma 0.655581 Carcinoma lobulillar 0.625171 tipo estadio iiib 0.641656 especial parientes 0.620527 crecimiento her2 0.616687 cáncer quizás 0.765886 genes brca1 0.623395 siguientes pruebas 0.678579 siguientes sumarios 0.647742	CLICK HERE
1934	National Cancer Institute	Html	es	Tratamiento del osteosarcoma e histiocitoma fibroso maligno óseo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del osteosarcoma e histiocitoma fibroso maligno óseo.	siguientes procedimientos 0.506474 células madre 0.526262 pequeña cantidad 0.50899 siguientes especialistas 0.504251 siguientes tipos 0.504112 rayos x 0.523233 tejido óseo 0.519779 enlace drugs approved 0.505077 suficiente tejido 0.503088 fibroso maligno óseo 0.821835 efectos tardíos 0.529504 PDQ Efectos tardíos 0.509684 National Cancer Institute 0.502454 siguientes riesgos 0.501964 médula ósea también 0.505126	Instituto Nacional 0.509248 PDQ Tratamiento 0.523403 determinados cambios 0.501954 alta potencia 0.503883 nuevos tipos 0.503233 Physician Data Query 0.509387 cáncer óseo 0.512408 siguientes situaciones 0.505889 Bone Cancer 0.502772 siguientes enlaces 0.502451 células sanguíneas maduras 0.509706 célula madre 0.502683 siguientes pruebas 0.512226 fibroso maligno 0.960799	CLICK HERE
3579	National Cancer Institute	Html	en	Cancer Health Disparities Research	NCI is addressing cancer health disparities through its efforts in basic research, community-level programs, and more.	cancer treatment 0.363689 cancer control continuum—from 0.369693 health care disparities 0.45285 American Cancer Society 0.373854 Breast Cancer Genetic 0.374611 NCI research programs 0.364956 cancer health disparities—such 0.406746 colorectal cancer 0.373832 American Breast Cancer 0.39202 Colorectal Cancer Outreach 0.36747 public health officials 0.365199 breast cancer outcome 0.373209 clinical cancer research 0.388692 Reduce Cancer Health 0.386549 health care facilities 0.400047 Breast Cancer Consortium 0.371087 population groups 0.362749 African American Breast 0.367467 care delivery research 0.356797 public health communities 0.394704 cancer health disparities 0.942995 NCI-Designated Cancer Centers. 0.367758 Documented cancer health 0.404937 certain racial/ethnic populations 0.356837 cancer research community 0.391405	Cancer Health Equity 0.385722 cancer research continuum 0.381244 cancer prevention 0.353808 prostate cancer deaths 0.379501 health disparities research 0.467802 cancer research 0.471213 African American men 0.354676 cancer screenings 0.355012 cancer screening rates 0.368257 cancer care—from access 0.379244 Breast Cancer Epidemiology 0.371467 African American women 0.401312 complex health care 0.371446 advanced cancer diagnoses—in 0.382581 community health educators 0.353702 breast cancer 0.431984 cancer care delivery 0.39176 cancer disparities 0.490093 NCORP cancer care 0.377954 experience cancer-related health 0.363186 cancer clinical trials 0.389742 cancer risk 0.352747 cancer death rates 0.384903 cancer incidence 0.357189	CLICK HERE